In fact, NADPH oxidase is activated in the brains of AD patients [7] and the catalytic subunit (gp91) is upregulated in Parkinson's disease (PD) [8], further implicating the enzyme complex in neurodegenerative diseases. The gene discussed is FMO5; the disease is Parkinson disease.